ALFA Finder| Revenue growth | 22% YoY in Q4 FY26. |
|---|---|
| Margins | Consolidated EBITDA margins sustained at 17.8%. |
| Demand visibility | Stable across core and emerging applications. |
| Management confidence | High; promoters infused ₹161cr capital. |
Growth
Q4 FY26 Revenue up 22%; Standalone PAT surged 182% YoY (low base effect). Consolidated FY26 Revenue grew 11%.
Outlook
FY27 revenue guidance: ₹875–950cr (standalone). Significant expansion in Electrolytes and Lithium Salts at Pakhajan and Dahej.
Risks
Supply chain disruptions, elevated input costs from Middle East tensions, and increased finance costs from high CAPEX.
Earnings Call filed with BSE, NSE: NEOGEN. Summary written with AI assistance from the document.
Neogen Chemicals Ltd: key numbers
- Share price
- ₹2,795.40
- Market cap
- ₹8,398 Cr
- Revenue (annual)
- ₹862.0 Cr
- Net profit (annual)
- ₹28.75 Cr
- P/E (TTM)
- 207.8×Sector 35.5×
- Promoter holding
- 48.31%-4.70% QoQ
- FII holding
- 4.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neogen Chemicals Ltd
All →Neogen Chemicals Regulatory Approval
Neogen Chemicals received GPCB's revocation of its Dahej plant direction and a CC&A amendment for manufacturing. The revocation is for three months with conditions attached.
Neogen Chemicals Other Announcement
A HUF of a director of Neogen's wholly owned subsidiary sold 2,361 shares on 5-6 November 2026. Sale consideration totals about ₹0.59 crore.
- Value
- ₹0.59 Cr
Neogen Chemicals Annual General Meeting
Neogen Chemicals seeks shareholder approval via postal ballot for related party transactions with a step-down subsidiary. E-voting runs until December 6, 2026.
Neogen Chemicals Earnings Call Transcript: Key Takeaways
Revenue rose 42% to ₹296 Cr and consolidated PAT rose 144% to ₹8 Cr, but a large standalone-to-consolidated gap shows the Neogen Ionics drag. Net debt is ₹1,095 Cr, and management gave no hard quarterly target to test against.
Neogen Chemicals Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue INR 296 Cr (+42%), EBITDA INR 45 Cr (+51%), PAT INR 8 Cr (+144%). Battery Chemicals revenue INR 37 Cr; Organolithium capacity expansion approved.
Neogen Chemicals Results Update
Neogen Chemicals issued its Q2 FY27 press release on unaudited results, showing higher year-on-year revenue and profit. Battery chemicals ramp-up and the QIP proceeds featured prominently.